Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cardiome Pharma Corporation (TSE: COM)

 
COM Technical Analysis
5
As on 31st Oct 2017 COM Share Price closed @ 2.27 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.09 & Strong Sell for SHORT-TERM with Stoploss of 2.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

COM Share Price

Open 2.01 Change Price %
High 2.34 1 Day 0.28 14.07
Low 1.90 1 Week 0.00 0.00
Close 2.27 1 Month -0.23 -9.20
Volume 54025 1 Year -1.74 -43.39
52 Week High 6.06 | 52 Week Low 1.64
 
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
LSG 2.08 8.33%
TBE 0.03 0.00%
ECA 15.09 4.43%
SC 60.83 -0.44%
PRE 0.64 0.00%
ELD 1.62 -6.90%
MFC 25.94 -0.04%
CPG 10.61 4.53%
BBD-B 2.73 -1.09%
 
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
GGA 0.06 20.00%
ANX 0.07 16.67%
ANX 0.07 16.67%
COM 2.27 14.07%
 
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
NXJ 2.35 -10.31%
NXJ 2.35 -10.31%
RN 0.09 -10.00%
RN 0.09 -10.00%
CTU-A 0.19 -9.52%
TNP 0.90 -9.09%
TNP 0.90 -9.09%
TNX 0.34 -8.11%
QEC 0.74 -7.50%
 
 
COM
Daily Charts		 COM
Intraday Charts		 Whats New @
Bazaartrend		 COM
Free Analysis
 
COM Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE2.68
RESISTANCE2.51
SUPPORT2.03
SUPPORT1.86
SUPPORT0.00
SUPPORT0.00
 
COM Target for Month January
Share
4th UP TARGET4.25
3rd UP TARGET3.62
2nd UP TARGET3.22
1st UP TARGET2.83
1st DOWN TARGET1.71
2nd DOWN TARGET1.32
3rd DOWN TARGET0.92
4th DOWN TARGET0.29
 
COM Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
COM Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
COM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
COM Address
COM
 6190 Agronomy Road
Suite 405
Vancouver, BC V6T 1Z3
Canada
Phone: 604-677-6905
Fax: 604-677-6915
 
COM Latest News
 
Your Comments and Response on Cardiome Pharma Corporation
 
COM Business Profile
Cardiome Pharma Corp., a biopharmaceutical company, is engaged in the development and commercialization of cardiovascular therapies that enhance the life and health of patients. It offers BRINAVESS (vernakalant IV), for conversion of recent onset atrial fibrillation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The companyÂ’s pre-clinical research and development focuses on modulating cellular proteins (ion channels) that gate the movement of ions across the cell membrane to control various functions, including contraction of muscles, secretion from glands, and responses to foreign bodies and inflammation. It has operations in Canada, the United States, Switzerland, and the United Kingdom. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service